TZ-1

N/A

Report date: 2025/01/26 17:41:26

Base Information

Drug NameTZ-1
Drug Alias NameIGF-1R inhibitor mAb (MedImmune/The Ohio State University)TZ-1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSomatomedin receptors modulators
TargetsSomatomedin receptors
Therapy Area/IndicationsSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedimmune Llc
China Registration ClassN/A

Develop Information

Active CompaniesThe Ohio State UniversityMedimmune Llc
Inactive CompaniesN/A
Active IndicationsSarcoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A